DYN Q1 2025 Earnings — Dyne Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

DYNDyne Therapeutics, Inc.

$3B

Q1 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$122M

Net Income

-$115M

EPS (Diluted)

$-1.05

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$106M

Free Cash Flow

-$107M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$721M

Total Liabilities

$52M

Stockholders' Equity

$669M

Cash & Equivalents

$472M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$122M	-$69M	-76.9%
Net Income	-$115M	-$66M	-75.7%